This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

A Blowout Call on Biotech Select

I have two simple goals with this brief missive: Give well-deserved kudos to Adam Feuerstein for his call on CV Therapeutics (CVTX) that he recently added to the portfolio of Biotech Select, a premium service from And second, if you're interested in biotech stocks, you should subscribe to Biotech Select.

Adam added CV Therapeutics to the model portfolio of Biotech Select on Jan. 20, when the stock was trading at $10.75 a share. Shares of CVTX rose to $16.68 in intraday trading today on news that the company had received and rejected a $16-per-share takeover offer from Japanese drugmaker Astellas.

Subscribers of Biotech Select who followed Feuerstein's buy suggestion gained more than 50% from this position in just five trading days!

Nice work, Adam. Click here to take a free trial to Biotech Select and receive all of Adam's commentary and stock recommendations.

Let's stay interactive.

Dave Morrow


David Morrow is editor-in-chief of In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
AAPL $132.50 0.84%
FB $80.95 0.58%
GOOG $542.06 -0.08%
TSLA $245.41 -0.08%
YHOO $43.71 0.08%


DOW 18,218.71 -67.03 -0.37%
S&P 500 2,130.88 +0.06 0.00%
NASDAQ 5,101.8630 +11.0690 0.22%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs